» Authors » L F Barcellos

L F Barcellos

Explore the profile of L F Barcellos including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 40
Citations 679
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hedstrom A, Adams C, Shao X, Schaefer C, Olsson T, Barcellos L, et al.
Mult Scler J Exp Transl Clin . 2020 Jul; 6(2):2055217320928101. PMID: 32728476
Background: Breastfeeding as an infant appears protective against later development of some autoimmune diseases, but research into its influence on multiple sclerosis (MS) risk has yielded inconclusive results. Objective: We...
2.
Gianfrancesco M, Balzer L, Taylor K, Trupin L, Nititham J, Seldin M, et al.
Genes Immun . 2016 Jul; 17(6):358-62. PMID: 27467283
Systemic lupus erythematous (SLE) is a chronic autoimmune disease associated with genetic and environmental risk factors. However, the extent to which genetic risk is causally associated with disease activity is...
3.
Hedstrom A, Mowry E, Gianfrancesco M, Shao X, Schaefer C, Shen L, et al.
J Neurol Neurosurg Psychiatry . 2016 Mar; 87(5):454-60. PMID: 26940586
Objective: Previous studies on consumption of caffeine and risk of multiple sclerosis (MS) have yielded inconclusive results. We aimed to investigate whether consumption of coffee is associated with risk of...
4.
Briggs F, Leung L, Barcellos L
Genes Immun . 2014 Jul; 15(7):466-76. PMID: 25030428
There is a strong and complex genetic component to multiple sclerosis (MS). In addition to variation in the major histocompatibility complex (MHC) region on chromosome 6p21.3, 110 non-MHC susceptibility variants...
5.
Morris D, Fernando M, Taylor K, Chung S, Nititham J, Alarcon-Riquelme M, et al.
Genes Immun . 2014 Mar; 15(4):210-7. PMID: 24598797
Systemic lupus erythematosus (SLE) is a clinically heterogeneous disease affecting multiple organ systems and characterized by autoantibody formation to nuclear components. Although genetic variation within the major histocompatibility complex (MHC)...
6.
Walsh K, Chokkalingam A, Hsu L, Metayer C, de Smith A, Jacobs D, et al.
Leukemia . 2013 Apr; 27(12):2416-9. PMID: 23615557
No abstract available.
7.
Bronson P, Goldstein B, Ramsay P, Beckman K, Noble J, Lane J, et al.
Genes Immun . 2011 May; 12(8):667-71. PMID: 21614020
The major histocompatibility complex (MHC) class II transactivator gene (CIITA) encodes an important transcription factor required for human leukocyte antigens (HLA) class II MHC-restricted antigen presentation. MHC genes, including the...
8.
Bronson P, Ramsay P, Seldin M, Gregersen P, Criswell L, Barcellos L
Genes Immun . 2011 Jan; 12(3):235-8. PMID: 21248776
The major histocompatibility complex (MHC) class II transactivator gene (CIITA) encodes an important transcription factor regulating genes required for human leukocyte antigen (HLA) class II MHC-restricted antigen presentation. MHC genes,...
9.
Ban M, McCauley J, Zuvich R, Baker A, Bergamaschi L, Cox M, et al.
Genes Immun . 2010 Jun; 11(8):660-4. PMID: 20574445
Several single-nucleotide polymorphism (SNP) genome-wide association studies (GWASs) have been completed in multiple sclerosis (MS). Follow-up studies of the variants with the most promising rankings, especially when supplemented by informed...
10.
Bronson P, Ramsay P, Seldin M, Gregersen P, Criswell L, Barcellos L
Genes Immun . 2010 Mar; 11(6):504-8. PMID: 20220768
CLEC16A, a putative immunoreceptor, was recently established as a susceptibility locus for type I diabetes and multiple sclerosis. Subsequently, associations between CLEC16A and rheumatoid arthritis (RA), Addison's disease and Crohn's...